Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Skandia in connection with its investment in Lumera
Mandate

Vinge advises Skandia in connection with its investment in Lumera

June 27, 2023 Banking and Finance M&A

Vinge has advised Skandia in connection with its acquisition of a minority stake in Lumera from Monterro.

In connection therewith AMF is also acquiring a minority stake from Monterro, and Monterro is reinvesting in Lumera through its M4 fund, which means that Monterro remains the majority shareholder through its M2 and M4 funds. Lumera is a software company that develops business systems for the life and pension insurance industry, including a cloud-based system that administers insurance policies.

Vinge's team consisted of Viveka Classon, Samra Tesser, Jonna Bondemark and Philip Moré.

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026